Business Wire

STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...
Business Wire

STAAR Surgical Announces First Implants of EVO Visian ICL in the U.S.

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...
KELOLAND News

Evo Visian® ICL Launches in the U.S.; an Evolutionary Vision Correction Procedure to Treat Nearsightedness is Now Available at Coastal Vision Medical Group

CHINO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- EVO Visian® ICL ("EVO") is an evolutionary, clinically-proven implantable lens that corrects common vision problems such as nearsightedness and ...
WGN-TV

EVO VISIAN® ICL NOW AVAILABLE IN THE US: PARKHURST NUVISION OF SAN ANTONIO TEXAS AMONG FIRST IN THE UNITED STATES TO OFFER THIS EVOLUTIONARY VISION ...

San Antonio, Texas, March 28, 2022 (GLOBE NEWSWIRE) -- EVO Visian® ICL (referred to as “EVO”) is an evolutionary innovation in vision correction surgery. EVO ICL is an implantable lens placed just ...
Daily Herald

Kovach Eye Institute first in Illinois to offer patients new EVO/EVO+ Visian® Implantable Collamer® Lens

In March 2022, the U.S. Food and Drug Administration (FDA) granted approval of the EVO/EVO+ Visian Implantable Collamer Lens (EVO) for the correction of myopia and myopia with astigmatism. Myopia is ...
Los Angeles Business Journal

Staar Receives Two Overseas Approvals for Visian

Shares of Staar Surgical Co. jumped 11 percent on Tuesday after the maker of implantable eye lenses said it had received regulatory approval to sell a product in Korea and Argentina. The Monrovia ...